| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
5,560,000,000 |
| Market
Cap: |
163.96(B) |
| Last
Volume: |
46,301,904 |
Avg
Vol: |
30,564,972 |
| 52
Week Range: |
$25.26 - $40.28 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
| |
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 6.5 |
| Insider 3/6 Months : 7.1 |
|
| Guru Rank Number : 710 |
| Guru Rank Value : 1.7 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Pfizer is a research-based biopharmaceutical company. Co. is engaged in the discovering, developing, manufacturing, marketing, sales and distribution of biopharmaceutical products. Co.'s business includes: internal medicine, which includes cardiovascular metabolic and pain products; oncology, which includes products in biologics, small molecules, immunotherapies, and biosimilars for cancers; hospital, which includes Co.'s portfolio of sterile injectable and anti-infective medicines, as well as Pfizer CentreOne; vaccines, which includes vaccines brands in pneumococcal disease, meningococcal disease, tick-borne encephalitis and COVID-19; inflammation and immunology; and rare disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
3,000 |
3,000 |
5,000 |
| Total Buy Value |
$0 |
$79,401 |
$79,401 |
$156,406 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
14,130 |
| Total Sell Value |
$0 |
$0 |
$0 |
$624,281 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lankler Douglas M |
Executive Vice President |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,722 |
113,623 |
|
- |
|
| Hill Charles H |
Executive Vice President |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,200 |
106,264 |
|
- |
|
| Germano Geno J |
Group President |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
28,134 |
291,834 |
|
- |
|
| Susman Sally |
Executive Vice President |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,630 |
241,222 |
|
- |
|
| Read Ian C |
Chairman & CEO |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
100,031 |
1,359,216 |
|
- |
|
| Johnson Rady A |
Executive Vice President |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,470 |
29,327 |
|
- |
|
| Cangialosi Loretta V |
Sr. Vice President, Controller |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,689 |
199,199 |
|
- |
|
| Bourla Albert |
Group President |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,722 |
95,393 |
|
- |
|
| Young John D |
Group President |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
28,134 |
108,647 |
|
- |
|
| Damelio Frank A |
Executive Vice President |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
33,214 |
433,913 |
|
- |
|
| Lewis-Hall Freda C |
Executive Vice President |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
14,848 |
132,886 |
|
- |
|
| Olson Laurie J |
Executive Vice President |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,486 |
56,567 |
|
- |
|
| Maddaluna Anthony J |
Executive Vice President |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,332 |
91,514 |
|
- |
|
| Germano Geno J |
Group President |
• • – |
2014-02-26 |
4/A |
D |
$31.99 |
$629,179 |
D/D |
(19,668) |
264,320 |
|
- |
|
| Dolsten Mikael |
President R&D |
• • – |
2014-02-26 |
4 |
D |
$31.99 |
$921,056 |
D/D |
(28,792) |
351,445 |
|
- |
|
| Dolsten Mikael |
President R&D |
• • – |
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
64,581 |
380,237 |
|
- |
|
| Lankler Douglas M |
Executive Vice President |
• • – |
2014-02-26 |
4 |
D |
$31.99 |
$932,668 |
D/D |
(29,155) |
101,901 |
|
- |
|
| Lankler Douglas M |
Executive Vice President |
• • – |
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,494 |
131,056 |
|
- |
|
| Lankler Douglas M |
Executive Vice President |
• • – |
2014-02-26 |
4 |
OE |
$12.70 |
$439,014 |
D/D |
34,568 |
120,562 |
|
- |
|
| Hill Charles H |
Executive Vice President |
• • – |
2014-02-26 |
4 |
D |
$31.99 |
$1,190,060 |
D/D |
(37,201) |
91,064 |
|
- |
|
| Hill Charles H |
Executive Vice President |
• • – |
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
24,219 |
128,265 |
|
- |
|
| Hill Charles H |
Executive Vice President |
• • – |
2014-02-26 |
4 |
OE |
$12.70 |
$441,084 |
D/D |
34,731 |
104,046 |
|
- |
|
| Germano Geno J |
Group President |
• • – |
2014-02-26 |
4 |
D |
$31.99 |
$649,013 |
D/D |
(20,288) |
263,700 |
|
- |
|
| Germano Geno J |
Group President |
• • – |
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
50,231 |
283,988 |
|
- |
|
| Susman Sally |
Executive Vice President |
• • – |
2014-02-26 |
4 |
D |
$31.99 |
$3,870,534 |
D/D |
(120,992) |
225,592 |
|
- |
|
1391 Records found
|
|
Page 30 of 56 |
|
|
0.18 (0.61%) 
